MeSH tree: E04.936.225
A research team led by the University of Minnesota Medical School demonstrated that the socioeconomic status (SES) of cell donors affects the health outcomes of blood cancer patients who underwent hematopoietic cell transplantation ...
Jul 17, 2024
0
50
Vanderbilt University Medical Center (VUMC) researchers are touting data from a multicenter, international Phase II clinical trial showing a new, curative treatment for sickle cell disease (SCD).
Jun 26, 2024
0
49
The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile myelomonocytic leukemia (JMML) enrolled in a Phase II clinical trial, with seven of 10 patients ...
Jun 13, 2024
0
25
New research in the June 2024 issue of Journal of the National Comprehensive Cancer Network highlights a promising approach for alleviating distress, enhancing quality of life, improving physical function, and reducing fatigue ...
Jun 11, 2024
0
65
When the myelin sheath that surrounds nerve fibers in the brain and spinal cord becomes damaged, a number of debilitating conditions can result that limit mobility, inhibit independence and reduce life expectancy. Multiple ...
Jun 6, 2024
0
39
Stem cell transplants can help ensure remission for some cancer patients. However, approximately 40% to 50% of cancer patients who have a type of stem cell transplant where cells are donated by another person experience a ...
Jun 3, 2024
0
20
For children who undergo bone marrow transplants, even mild respiratory infections can turn deadly. Now, scientists at UC San Francisco (UCSF) and Chan Zuckerberg Biohub San Francisco (CZ Biohub SF) and an international research ...
May 28, 2024
0
27
A new treatment approach using an older drug may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors, according to a study conducted by researchers ...
May 24, 2024
0
27
Madeleine Lehander from the Hematology Unit/HERM, at the Department of Medicine, Huddinge (MedH), is defending her thesis "Exploring T Cell Mediated Immunotherapy against Therapy Resistant Leukemic Stem Cells," on 24 May ...
May 20, 2024
0
30
Researchers at Peter Mac have found a new way to treat a form of leukemia that stops the disease in its tracks to prolong remission.
Apr 15, 2024
0
56
